#surgpath

GLOBAL JOURNAL OF PATHOLOGY & LABORATORY MEDICINE

Don't pass up the opportunity to get your research published in Global Journal of Pathology & Laboratory Medicine.

ISSN 2754-0952

Submit your papers here: https://www.ucjournals.com/global-journal-of-pathology-laboratory-medicine/

GLOBAL JOURNAL OF PATHOLOGY & LABORATORY MEDICINE

Don't ignore the chance to get your article published in Global Journal of Pathology & Laboratory Medicine.

ISSN 2754-0952

Submit your papers here: https://www.ucjournals.com/global-journal-of-pathology-laboratory-medicine/

Abstract

The most fatal kind of cancer in women worldwide still is breast cancer. In order to improve care for women with breast cancer around the world, this study examines some of the epidemiological parallels and differences in breast cancer between white European women and black African women. African women experience breast cancer at a lower rate than their European counterparts. The majority of breast cancer patients in Europe are postmenopausal; however, premenopausal women in Africa have the highest incidence of the disease. The most typical kind of breast cancer in women in Africa and Europe is ductal carcinoma. However, compared to Europe, Africa has a higher prevalence of medullary and mucinous carcinomas. African women typically present late for treatment, which results in worse survival rates, whereas European women typically present at an early stage, especially with the advent of screening. African women should be the subject of additional molecular study to find out what genetic variables may increase their risk of breast cancer. To optimise care for women with breast cancer, the health care system in Africa should also be improved.

Breast cancer epidemiology in Europe and Africa:-

The Institute of Medical Education, Cardiff University School of Medicine, 5th Floor, Cochrane Building, Heath Park, CardiffCF14 4XW, UK2 is run by Ganiy Opeyemi Abdulrahman Jnr.1 and Ganiyu Adebisi Rahman. Ilorin 240001, Nigeria, University of Ilorin Teaching Hospital, Department of Surgery, and Division of General Surgery Please contact Ganiy Opeyemi Abdulrahman Jr. via email at [email protected]. Submitted on September 29, 2011, revised on February 19, 2012, and approved on March 11, 2012. P. Vineis is the academic editor. G. O. Abdul Rahman Jr. and G. A. Rahman, 2012, all rights reserved. The Creative Commons Attribution License, which this open access paper is given under, allows for free use, distribution, and reproduction in any format as long as the original work is properly attributed. The most fatal kind of cancer in women worldwide still is breast cancer. In order to improve care for women with breast cancer around the world, this study examines some of the epidemiological parallels and differences in breast cancer between white European women and black African women. African women experience breast cancer at a lower rate than their European counterparts. The majority of breast cancer patients in Europe are postmenopausal; however, premenopausal women in Africa have the highest incidence of the disease. The most frequent type of breast cancer in women in Africa and Europe is ductal carcinoma. Mucinous and medullary carcinomas, however, are more prevalent in Africa than in Europe. African women typically present late for treatment, which results in worse survival rates, whereas European women typically present at an early stage, especially with the advent of screening. African women should be the subject of greater molecular study to determine the hereditary elements that may increase their risk of breast cancer. To optimise care for women with breast cancer, the health care system in Africa should also be improved.

Inauguration:-

The worst form of cancer for women worldwide is breast cancer. Worldwide, there were over 1.4 million breast cancer diagnoses in 2008, and there were 460000 deaths as a result. Of these, it is estimated that 450000 women in Europe received the disease diagnosis; there were correspondingly 140000 fatalities, and 68000 women reportedly received the same diagnosis in Africa; there were correspondingly 37000 deaths. Numerous studies have revealed that the epidemiology of breast cancer in women in Europe and Africa may differ from one another. Blacks and whites have been demonstrated to have different relationships with breast cancer in terms of risk factors include menopausal usage, oral contraceptive use, cigarette smoking, and family history of the disease. In order to better understand the epidemiological similarities and differences between breast cancers in white European women and black African women, this paper will examine a few of those topics.

2. Probability:-

With over 16000 fatalities and almost 30000 new cases in 2008, breast cancer was the top cause of death for women in West Africa. With about 18000 new cases and 10000 deaths over the same year, Eastern Africa appears to have a substantially lower incidence. Five times more cases occur in Western Europe than in West Africa. Additionally, the number of breast cancer fatalities in 2008 was estimated to be around 40,000. Similar rates of occurrence—115,000 new cases and more than 47000 fatalities in 2008—can be found throughout Central and Eastern Europe. Additionally, it has been demonstrated that among American women of European ancestry, the incidence is significantly higher. Greater European ancestry has been linked to a higher risk of developing breast cancer, according to Fejerman and colleagues.

Conclusion:-

Review of the epidemiological parallels and divergences in breast cancer among females in Europe and Africa. African women should be the subject of additional molecular study to find out what genetic variables may increase their risk of breast cancer. In order to maximise care for women with breast cancer, the African health care system needs to be improved.

Contact Us:-

Reach out to us: https://breastcancerpathology.universeconferences.com/ Mail: [email protected]| [email protected] |                                                                            [email protected] Whatsapp: +442033222718 Call: +12073070027

Previous Blog Post Links:-

https://www.linkedin.com/pulse/how-lessen-your-risk-developing-breast-cancer-sweta-pradhan

https://sites.google.com/view/breast-cancer-developing-risk/home

https://drandreaross.blogspot.com/2022/07/how-to-lessen-your-risk-of-developing.html

https://kikoxp.com/posts/13701

https://medium.com/@BreastPathology/how-to-lessen-your-risk-of-developing-breast-cancer-a2f9f1f4d27a

https://www.tumblr.com/blog/view/breastpathology/690459174616825856?source=share

https://qr.ae/pvkfyR

https://www.linkedin.com/pulse/how-lessen-your-risk-developing-breast-cancer-dr-priya-pujhari

https://www.tumblr.com/blog/view/breastpathology/690368008546369536?source=share

https://www.linkedin.com/pulse/following-mastectomy-breast-reconstruction-dr-priya-pujhari

https://medium.com/@BreastPathology/following-a-mastectomy-breast-reconstruction-b14d25d791a5

How to lessen your risk of developing breast cancer:-

The first step in preventing breast cancer is to adopt healthy habits, like reducing alcohol use and engaging in regular physical activity. Be aware of the steps you can take to lower your risk of developing breast cancer.

If you're worried that breast cancer will strike, you may be asking if there are any precautions you can take to lessen the risk. It is impossible to change some risk factors, such family history. You can reduce your risk by making some lifestyle changes, though.

Choosing a Breast Reconstruction Procedure:-

Reconstruction surgery is a popular choice among women, but it may not be suitable for everyone. Learn more about breast reconstruction's advantages and disadvantages as well as your other options.

Alternatives for Breast Reconstruction:-

Breast reconstruction methods come in a wide variety of forms. Some are carried out (or begun) concurrently with mastectomy or lumpectomy, while others are carried out subsequently. Understand your choices better.

Learn what to anticipate:-

Being ready is essential if you intend to undergo breast reconstruction surgery. Learn what your surgeon should tell you to expect and what to expect both before and after your operation.

Breast Cancer Prevention and Risk:-

Breast cancer cannot be entirely avoided. However, there are things you can do to potentially reduce your risk, such as modifying risk variables that are within your power to change.

The causes of breast cancer risk factors:-

Anything that makes you more likely to get a disease like cancer is a risk factor. Although having one or more risk factors does not guarantee that you will develop the disease, it does increase your risk. Several risk factors for breast cancer—family history and aging, for instance—cannot be changed, but there are some that you can.

Breast cancer: Is it preventable?

Breast cancer cannot be entirely avoided. However, there are certain things you may do to perhaps reduce your risk. This can be especially beneficial for women who have certain breast cancer risk factors, like a long family history of the disease or specific inherited gene alterations.

How can I lower my risk of developing breast cancer?

According to research, even among high-risk women, changing one's lifestyle can lower the risk of developing breast cancer. Reduce your risk by:

Drink in moderation. Your risk of developing breast cancer rises as you consume more alcohol. According to research on the impact of alcohol on breast cancer risk, the general advice is to limit your intake to one drink per day, as even little amounts raise risk.

Keep a healthy weight. Work to keep up a healthy weight if you have one. Ask your doctor for advice on appropriate weight-loss methods if you need to. Reduce your daily calorie intake and gradually increase the amount of exercise.

Get some exercise. You can avoid breast cancer by eating a nutritious diet and exercising regularly. The majority of healthy adults should aim for 75 minutes per week of strenuous aerobic activity or at least 150 minutes per week of moderate aerobic activity, plus at least twice per week of strength training.

Breast-feed. The prevention of breast cancer may be aided by breastfeeding. The protective effect increases with breastfeeding duration.

Limit postmenopausal hormone replacement therapy. Breast cancer risk may rise with combination hormone therapy. Ask your doctor about the advantages and disadvantages of hormone therapy. With the help of nonhormonal therapy and drugs, you may be able to control your symptoms.

Can breast cancer be prevented with a good diet?

A nutritious diet may lower your risk of developing some cancers, as well as diabetes, heart disease, and stroke. For instance, extra-virgin olive oil and mixed nuts may lower the incidence of breast cancer in women who follow a Mediterranean diet. The majority of the foods that make up the Mediterranean diet are plant-based, including fruits, vegetables, whole grains, legumes, and nuts.

The Mediterranean diet substitutes fish for red meat and favours healthy fats like olive oil over butter. Keeping a healthy weight is essential for preventing breast cancer.

Is there a connection between breast cancer and birth control pills?

According to some research, hormonal contraception, which includes hormone-releasing IUDs and birth control pills, raises the risk of breast cancer. The risk is thought to be extremely low, though, and it goes down once you stop using hormonal contraceptives.

According to a new study linking hormonal contraceptive use to breast cancer, one more case of the disease can be anticipated for every 7,690 women who use hormonal contraception for at least a year.

Consult your doctor about your contraception alternatives. Also take into account the advantages of hormonal contraception, which include regulating menstrual bleeding, avoiding an unexpected pregnancy, and lowering the risk of several diseases, such as ovarian and endometrial cancer.

Anything else I can do?

Be on the lookout for breast cancer. Consult your doctor if you detect any changes in your breasts, such as a new lump or skin changes. Additionally, according on your medical history, ask your doctor when to start mammograms and other screenings.

Contact Us:-

Reach out to us: https://breastcancerpathology.universeconferences.com/ Mail: [email protected]| [email protected] |                                                                            [email protected] Whatsapp: +442033222718 Call: +12073070027

Previous Blog Post Links:-

https://sites.google.com/view/bone-and-soft-tissue-pathology/home

https://drandreaross.blogspot.com/2022/07/bone-and-soft-tissue-pathology.html

https://kikoxp.com/posts/13610

https://medium.com/@BreastPathology/bone-and-soft-tissue-pathology-c56689328673

https://www.tumblr.com/blog/view/breastpathology/690201931232247808?source=share

https://qr.ae/pvkiPJ

https://www.linkedin.com/pulse/bone-soft-tissue-pathology-sweta-pradhan

https://www.linkedin.com/pulse/bone-soft-tissue-pathology-dr-priya-pujhari

https://www.linkedin.com/pulse/following-mastectomy-breast-reconstruction-sweta-pradhan

https://qr.ae/pvk3RB

https://www.tumblr.com/blog/view/breastpathology/690368008546369536?source=share

https://www.linkedin.com/pulse/following-mastectomy-breast-reconstruction-dr-priya-pujhari

https://medium.com/@BreastPathology/following-a-mastectomy-breast-reconstruction-b14d25d791a5

https://kikoxp.com/posts/13679

https://drandreaross.blogspot.com/2022/07/following-mastectomy-breast.html

Bone and Soft Tissue Pathology:-

Introduction:-

The study of neoplastic and non-neoplastic diseases of the soft tissues, including muscle, adipose tissue, tendons, fascia, and connective tissues, is the focus of the surgical pathology specialist known as soft tissue pathology. It can be difficult for a pathologist to make a firm diagnosis of many soft tissue cancers using only gross inspection and microscopy; therefore, additional tools such immunohistochemistry, electron microscopy, and molecular pathology procedures are occasionally used.

Pathologists at Massachusetts General Hospital as well as those in other parts of the United States and abroad can receive diagnostic assistance from the Division of Bone and Soft Tissue Pathology. Fellows educated by this organisation typically go on to become academic pathologists or specialists in large community hospitals with active orthopaedic and cancer services. Since 1986, the group's primary research initiatives have been on the clinicopathologic characteristics of numerous malignant diseases that affect the bones and soft tissues. The Radiology, Orthopaedics, Medical Oncology, and Medical Oncology departments at Mass General have worked with us on some of this work. The team is currently extending its research into the molecular genetics of malignancies of the soft tissue and bone.

The division at Mass General is an important component of the Connective Tissue Oncology Group, a multidisciplinary group of doctors devoted to the care of Mass General patients with cancers of the soft tissue and bone. We are moreover associates of the Brigham and Women's Hospital-affiliated Mass General Brigham Connective Tissue Oncology Group.

Therapeutic Program:-

4700 surgical specimens are provided as part of the service annually. About 20% of these cases involve benign and malignant neoplasms, with the remaining cases including a range of illnesses such arthritis, infection, metabolic abnormalities, mechanical issues, circulatory malfunction, and trauma. In addition to traditional light microscopy, many neoplasms need to be evaluated using complicated techniques such immunohistochemistry, electron microscopy, cytogenetics, FISH, and PCR.

One of the most frequent users of molecular genetics, electron microscopy, and immunohistochemistry is the service. Many private consult cases that are requested by pathologists and surgeons from across the United States and many international nations are not included in the volume of cases at Mass General.

Achievements in Education and Research:-

Brain Base Tumours:-

The division examines more surgical samples from tumours at the base of the skull than any other facility. Due to the department of radiation oncology's accessibility to proton beam radiation, which draws patients from all over the world, there are a lot of referrals.

Chondrosarcomas and chordomas make up the bulk of skull base tumours. The division has formally defined the morphology of these tumours in relation to their immunoprofile and prognosis in a number of studies. Importantly, these investigations have revealed that 37% of chordomas and chondrosarcomas receive the incorrect diagnosis at non-government facilities. When myxoid chondrosarcoma is misclassified as a chordoma, the majority of errors can be avoided by undergoing immunohistochemistry.

The identification of certain benign bone tumours that can be mistaken pathologically for chondrosarcomas, called chordomas, and the description of variants of chordomas that can be mistaken for benign processes are two more significant morphologic studies relevant to therapy and prognosis.

We recently published a sizable collection of paediatric chordomas, and we are currently examining a subgroup of kids with severe skull base chordomas.

We are investigating chordomas and precursor lesions in ferrets right now, and we just finished a comparative genomic hybridization investigation into chordomas.

Conclusion:-

Neoplasms and other pathological conditions that affect the skeletal system and many non-epithelial extraskeletal tissues, such as fibrous and adipose tissue, skeletal muscle, vessels, and peripheral nerves, are dealt with by the Bone and Soft Tissue Pathology Unit of the Department of Pathology and Cell Biology.

The analysis of a specimen's macroscopic and microscopic features is a part of the diagnostic process, but it is not the only one. In some circumstances, specialised methods like immunohistochemistry, cytogenetics, and molecular pathology are used to confirm the diagnosis. Surgeons, oncologists, and radiologists can also offer additional knowledge and experience.

Pathological and neoplastic disorders of the bone and soft tissue are quite uncommon, so it's crucial that a specialist who is familiar with their characteristics and biological potential makes the diagnosis.

Contact Us:-

Reach out to us: https://breastcancerpathology.universeconferences.com/ Mail: [email protected]| [email protected] |                                                                            [email protected] Whatsapp: +442033222718 Call: +12073070027

Previous Blog Post Links:-

https://www.linkedin.com/pulse/breast-cancer-pathology-dr-priya-pujhari

https://medium.com/@BreastPathology/breast-cancer-pathology-e91dca1a54f4

https://www.tumblr.com/blog/view/breastpathology/689752992891682816?source=share

https://kikoxp.com/posts/13488

https://qr.ae/pvkRN2

https://drandreaross.blogspot.com/2022/07/breast-cancer-pathology.html

https://www.linkedin.com/pulse/breast-cancer-pathology-sweta-pradhan

https://sites.google.com/view/breast-cancer-pathology/home

https://sites.google.com/view/breastcancerdiagnosis/home

https://drandreaross.blogspot.com/2022/07/learning-about-breast-cancer-diagnosis.html

https://kikoxp.com/posts/13582

https://medium.com/@BreastPathology/learning-about-a-breast-cancer-diagnosis-8c179f22c7de

https://qr.ae/pvkuZX

https://www.linkedin.com/pulse/learning-breast-cancer-diagnosis-dr-priya-pujhari

https://www.linkedin.com/pulse/learning-breast-cancer-diagnosis-sweta-pradhan

Don't miss the chance to publish your paper in Global Journal of Pathology & Laboratory Medicine.

ISSN 2754-0952

GLOBAL JOURNAL OF PATHOLOGY & LABORATORY MEDICINE

Don't miss the chance to publish your paper in Global Journal of Pathology & Laboratory Medicine.

ISSN 2754-0952